1. Introduction {#sec1}
===============

Tanycytic ependymoma is a World Health Organization (WHO) grade II tumor with histological characteristics distinct from the typical features of commonly encountered ependymomas. In these lesions, the classic ependymal rosettes and perivascular pseudorosettes are replaced by more fibrillar cells. Thus, the cellular appearance and arrangement may mimic other lesions such as schwannoma and astrocytoma, which makes the diagnosis challenging and hence warrants further evaluation. We present a rare case of an intramedullary spinal tumor in a 50-year-old man in whom the preliminary intraoperative diagnosis of schwannoma was revised to tanycytic ependymoma after the application of immunohistochemical stains and careful ultrastructural interpretation.

2. Case Presentation {#sec2}
====================

2.1. History and Examination {#sec2.1}
----------------------------

A 50-year-old man with a five-year history of progressively worsening upper extremity numbness presented to an outside physician with the recent onset of bilateral lower extremity numbness and gait disturbance. He was referred to our neurosurgery clinic after magnetic resonance (MR) imaging of the cervical spine revealed an intramedullary lesion at the C3--5 level. His neurologic examination showed that he had diminished soft touch and pinprick sensation involving both shoulders, arms, and hands along the C5, C6, and C7 dermatomal distributions. The patient was noted to be hyperreflexive, with 3+ brachioradialis and patellar reflexes, as well as myelopathic, with evident Hoffman sign and clonus and a positive Romberg sign. There was no evidence of bladder, bowel, and/or sexual dysfunction.

On MR imaging, the tumor measured 2.4 × 1.9 × 1.3 cm, spanning C3 through C5. It was avidly enhancing on T1-weighted imaging, mostly centered at the C4 level, and hypointense on T2-weighted imaging, with apparent hyperintensity at the inferior and superior poles of the lesion suggestive of vasogenic edema (Figures [1(a)](#fig1){ref-type="fig"}--[1(c)](#fig1){ref-type="fig"}).

2.2. Surgical Procedure and Outcome {#sec2.2}
-----------------------------------

The tumor was exposed via a C3--6 laminectomy. The craniocaudal extent of the lesion was identified with intraoperative ultrasound before we proceeded with the durotomy. After the durotomy was completed and the dural leaflets were reflected, a midline myelotomy was performed. The tumor was noted to be purplish in color and moderately vascular. There appeared to be a clear plane between the tumor and spinal cord; however, because of the large size of the tumor, a Cavitron ultrasonic surgical aspirator was first used to debulk the tumor and decompress the cord. After the tumor size was reduced, it became easier to mobilize the remainder of the mass, which allowed for the careful peeling of the ventral capsule and achievement of gross total resection (GTR) ([Figure 2](#fig2){ref-type="fig"}). Intraoperative neuromonitoring with somatosensory-evoked potentials and motor-evoked potentials remained stable.

2.3. Histopathological Analysis {#sec2.3}
-------------------------------

The frozen section showed spindle cells with oval and elongated nuclei with occasional hemosiderin deposits present (Figures [3(a)](#fig3){ref-type="fig"} and [3(b)](#fig3){ref-type="fig"}). There was moderate cellularity with no significant mitotic figures. A preliminary diagnosis of schwannoma was made based on the findings from the frozen section; however, immunohistochemical staining of the permanent section revealed strong immunoreactivity for glial fibrillary acidic protein (GFAP) with intermittent S-100 positivity, confirming that the tumor was of the tanycytic type of ependymoma ([Figure 3(c)](#fig3){ref-type="fig"}).

2.4. Postoperative Course {#sec2.4}
-------------------------

Because GTR of an ependymoma was achieved, no adjuvant therapy was implemented. The patient\'s postoperative course was uneventful. He experienced improvement in his bilateral lower extremity numbness with slight initial worsening in his upper extremity numbness, which later improved to better than baseline. The postoperative MR imaging showed complete resection with no evidence for recurrence. Sixteen months after surgery, the patient is free from recurrence.

3. Discussion {#sec3}
=============

Tanycytic ependymoma is a rare form of ependymoma that was initially described by Friede and Pollak in 1978 \[[@B1]\]. Like its cellular counterpart, it is a WHO grade II tumor in histology and behavior \[[@B2]\]. Interestingly, however, it does not carry the typical histological features of the cellular form and often bears close resemblance to both schwannoma and pilocytic astrocytoma, making its diagnosis a conundrum \[[@B3]\].

The tumor cells are derived from the tanycyte, which is a bipolar cell with long processes within the neuropil, bridging the ependymal lining with the capillary wall. Given its peculiar intertwined position, it is thought to function in establishing communication between the cerebrospinal fluid, the brain parenchyma, and the vasculature \[[@B4]\]. Tanycytes most often arise in the vicinity of the lateral or fourth ventricle and the spinal cord. In the cerebrum, tanycytes are most commonly located along the lateral wall of the third ventricle. In the spinal cord, however, they surround the central canal and radiate towards the grey matter \[[@B5]--[@B7]\]. Published reports indicate that most adult ependymomas are located in the spinal cord in an extra- or intramedullary location \[[@B8]\]. The reported tanycytic forms of ependymoma are almost always intramedullary lesions. Excluding our case, 25 other cases of tanycytic ependymomas have been reported in the literature, of which 17 cases involved the spinal cord and only 3 were extramedullary \[[@B2]\]. Our case of a cervical intramedullary tanycytic ependymoma raises the total number of spinal cord tanycytic ependymomas reported to 18 and exclusive cervical spine involvement to 7 ([Table 1](#tab1){ref-type="table"}).

Tanycytic ependymoma is of low-to-moderate cellularity characterized by a flow of elongated cells with nuclear pleomorphism. Mitotic figures are usually absent. It has inconspicuous features that are not typical of ependymoma. The distinctive perivascular pseudorosette pattern of ependymoma cells is infrequently encountered \[[@B9]\]. In a simple smear, the cells conglomerate in a cohesive cluster with their bipolar long processes coursing away from the vessel walls. Their nuclei are oval to spindle shaped with evident pleomorphism. The cell processes are not fluffy as with the cellular type of ependymoma \[[@B10]\].

Tanycytic ependymoma cells may mimic other tumor cells with similar features under light microscopy often lending to a challenging diagnosis. The spindle appearance of the cells, for instance, is similar to that of schwannoma cells. One distinguishing feature on a simple stain, however, is that tanycytic ependymoma cells are more uniform and their nuclei more oval compared with those of schwannoma cells. Similarly, the long processes arising from tanycytic ependymoma cells resemble those of pilocytic astrocytoma. Again, there are discerning features that set the tanycytic ependymoma cells apart from astrocytoma, such as the absence of Rosenthal fibers, the presence of large ovoid nuclei, tight perivascular packing of the cells, and their isomorphic cellular appearance \[[@B3], [@B9]\]. Those important subtleties can be missed when viewing under the light microscope with simple stains. In such instances, the pathologist should resort to immunohistochemical as well as ultrastructural characteristics that can help characterize the tumor type. Tanycytic ependymoma stains positive for GFAP and vimentin but rarely stains S-100. This helps to differentiate it from schwannoma, which is S-100 positive and GFAP negative. This histological predicament was well highlighted in our case, in which the intraoperative diagnosis on frozen section was thought to be schwannoma, but later immunohistochemical staining of the permanent section confirmed it was consistent with a tanycytic ependymoma. Although, pilocytic astrocytoma is GFAP positive, it almost never stains for vimentin, which helps to discriminate it from tanycytic ependymoma \[[@B11]\]. The electron microscopic features of well-developed cellular intermediate junctions as well as microvilli and cilia explain the ependymal nature of the tumor cells and narrow the likely diagnoses to schwannoma and ependymoma \[[@B2], [@B4], [@B9]\].

Radiographically, ependymoma usually enhances on T1-weighted imaging after administration of contrast agent and is often associated with a syrinx or hematoma. Whereas ependymoma is almost always intramedullary, schwannoma is almost always an extramedullary lesion that also avidly enhances on T1-weighted imaging with gadolinium contrast enhancement (Figures [1(b)](#fig1){ref-type="fig"} and [1(c)](#fig1){ref-type="fig"}). Pilocytic astrocytomas rarely enhance \[[@B11]\]. All the aforementioned histological and radiographic hallmarks are important in making a correct diagnosis, which has far-reaching implications with regards to anticipated prognosis, followup, and adjuvant therapy.

Intramedullary ependymomas of the cervical spine usually have an identifiable plane that allows for the safe achievement of GTR. Patients may experience initial neurological decline in the early postoperative period, and that risk increases with older patients. Fifty percent of patients who experience initial decline in their postoperative neurological status show an improvement to their preoperative baseline with continued improvement over the next year. Late improvement in motor, sensory, and bladder dysfunction may continue, especially in patients in whom a surgical plane could be identified \[[@B12]--[@B14]\]. With ependymomas, trends towards neurological improvement can be expected between 1 and 3 months and continue up to a year. Dysesthesias begin to improve within a month of surgery and are better by a year \[[@B13]\]. Regardless of tumor histopathology in patients with cervical intramedullary tumors, preoperative neurological status and GTR with an identifiable plane remain the best predictors of overall functional outcome \[[@B12]\].

4. Conclusion {#sec4}
=============

A rare case of spinal tanycytic ependymoma was presented in a 50-year-old-man. A careful and detailed histological inspection with utilization of immunohistochemical stains and ultrastructural microscopy may be necessary to distinguish tanycytic ependymoma from other neoplasm such as schwannoma and pilocytic ependymoma.
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![(a) Sagittal T2-weighted image of the cervical spine with an isointense lesion at C4-5 with surrounding T2 hyperintensity suggestive of edema. (b) Sagittal T1-weighted image with gadolinium enhancement showing an avidly enhancing lesion with surrounding cord edema. (c) Axial T1-weighted image with gadolinium enhancement revealing an intramedullary homogenously enhancing lesion with severe cord compression.](CRIM.NM2013-170791.001){#fig1}

![((a), (c)) Sagittal and axial gadolinium enhanced T1-weighted images of the cervical spine after C3--C6 laminectomies and tumor resection demonstrating GTR with no residual enhancement. ((b), (d)) Sagittal and axial T1-weighted inversion recovery images of the cervical spine after tumor resection demonstrating persistent cord syrinx and edema.](CRIM.NM2013-170791.002){#fig2}

![(a) Histological section showing spindle cell neoplasm of moderate cellularity arranged in interlacing fascicles. Hyalinized blood vessels and foci of hemosiderin pigment deposits are present. (b) Histological section showing neoplastic cells with oval to elongated nuclei with speckled chromatin and small nucleoli. (c) Histological section demonstrating cells that stained strongly positive for GFAP.](CRIM.NM2013-170791.003){#fig3}

###### 

Demographic and clinical characteristics of  18 patients with spinal cord tanycytic ependymoma cases.

  Author                               Sex   Age (years)   Affected level   Location     Treatment              Prognosis
  ------------------------------------ ----- ------------- ---------------- ------------ ---------------------- ------------------------------------------
  Friede and Pollak, 1978 \[[@B1]\]    F     38            C6-T3            Intradural   STR                    Unknown
  F                                    46    T7-L2         Intradural       Unknown      Unknown                
  M                                    45    C1-T1         Intradural       Unknown      Unknown                
  M                                    17    C1-C3         Intradural       Unknown      Unknown                
  F                                    36    C1-C6         Intradural       PR           Recurrence             
  F                                    35    T10-T11       Unknown          Unknown      Unknown                
                                                                                                                
  Spaar et al., 1986 \[[@B15]\]        F     52            T6-T7            Intradural   GTR                    Death due to post-operative complication
                                                                                                                
  Langford and Barré, 1997 \[[@B4]\]   M     32            C                Intradural   GTR                    No recurrence (2 yr)
                                                                                                                
  Kawano et al., 2001 \[[@B9]\]        M     45            T3-T4            Intradural   GTR                    No recurrence (9 yr)
  F                                    36    C3-C6         Intradural       Unknown      No recurrence (9 yr)   
  F                                    55    C7-T2         Intradural       Unknown      No recurrence (2 yr)   
                                                                                                                
  Kobata et al., 2001 \[[@B16]\]       M     30            T6-T11           Extradural   STR                    No regrowth (2 yr)
                                                                                                                
  Ueki et al., 2001 \[[@B17]\]         F     13            C7-T2            Intradural   GTR                    Unknown
                                                                                                                
  Dvoracek and Kirby, 2001 \[[@B3]\]   F     31            L5-S1            Intradural   STR                    No regrowth (8 months)
                                                                                                                
  Boccardo et al., 2003 \[[@B18]\]     F     39            C5-C6            Intradural   GTR                    No recurrence (2 yr)
                                                                                                                
  Sato et al., 2005 \[[@B11]\]         M     58            C2-C4            Intradural   STR                    No recurrence (2 yr)
                                                                                                                
  Ishihama et al., 2011 \[[@B8]\]      F     40            T10-T11          Extradural   GTR                    No recurrence (16 months)
                                                                                                                
  This paper                           M     50            C3-C5            Intradural   GTR                    No recurrence (16 months)

GTR: gross total resection; STR: subtotal resection; PR: partial resection.

[^1]: Academic Editors: K. Arnautovíc, Y. Iwadate, N. S. Litofsky, and D. Long
